Medical High Pressure Syringe Market Report 2026

Medical High Pressure Syringe Market Overview

• Medical High Pressure Syringe market size has reached to $1.64 billion in 2025 • Expected to grow to $2.4 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Surge In Minimally Invasive Procedures Fueling The Growth Of The Market Due To Rising Patient Demand For Quicker Recovery And Less Invasive Treatments • Market Trend: Sol-Millennium Launches Innovative Needle-Free Injection Device For Insulin Delivery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Medical High Pressure Syringe Market?

A medical high-pressure syringe is a specialized device used to inject contrast agents during imaging procedures like CT and MRI scans. It is designed to withstand the high pressures required for rapid and controlled delivery of fluids. These syringes ensure accurate dosing and enhanced imaging quality for diagnostic purposes. The main product types of medical high-pressure syringe are CT injector systems, MRI injector systems, angiographic injector systems. Contrast injectors are medical devices that are employed for injecting contrast media into the body to enhance the visibility of tissues for medical imaging procedures. The various materials include plastic syringes, glass syringes, metal syringe. These are used in various applications such as cardiology, radiology, urology, orthopaedics and also by various end users such as hospitals, diagnostic centers, ambulatory surgical centers.

What Is The Medical High Pressure Syringe Market Growth Forecast?

The medical high pressure syringe market size is expected to see strong growth in the next few years. It will grow to $2.4 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to growth of minimally invasive diagnostics, expansion of imaging infrastructure, technological advancement in injectors, demand for faster imaging procedures, rising chronic disease diagnostics. Major trends in the forecast period include rising use in advanced diagnostic imaging, demand for high-precision contrast delivery, growth of syringeless injector compatibility, increased focus on patient safety, adoption of disposable high-pressure syringes.

Global Medical High Pressure Syringe Market Segmentation

1) By Product Type: CT Injector Systems, MRI Injector Systems, Angiographic Injector Systems 2) By Material: Plastic Syringes, Glass Syringes, Metal Syringe 3) By Application: Cardiology, Radiology, Diagnostic Imaging Procedures, Interventional Imaging Procedures 4) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers Subsegments: 1) By CT Injector Systems: Single-head CT Injectors, Dual-head CT Injectors, Syringeless Injectors, 2) By MRI Injector Systems: MR-Compatible Injectors, Non-Ferromagnetic Injectors, Syringeless MRI Injectors 3) By Angiographic Injector Systems: Fixed Angiographic Injectors, Mobile Angiographic Injectors, Dual-syringe Injectors

What Is The Driver Of The Medical High Pressure Syringe Market?

The increasing demand for minimally invasive procedures is expected to propel the growth of the medical high pressure syringes market going forward. Minimally invasive procedures are medical techniques that use small incisions or non-invasive methods to perform surgeries or interventions with reduced tissue damage, faster recovery times, and less postoperative pain compared to traditional surgical methods. Minimally invasive procedures are increasing due to rising patient demand for quicker recovery and less invasive treatments, as they typically result in reduced hospital stays, lower complication risks, and faster return to daily activities. Medical high pressure syringes support minimally invasive procedures by enabling precise and controlled delivery of contrast media, which enhances imaging accuracy essential for guiding such interventions. For instance, in February 2024, according to the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, approximately 83% of all medical procedures performed in 2023 were minimally invasive, with standard surgical procedures accounting for the remaining 17%. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the medical high pressure syringes industry.

Key Players In The Global Medical High Pressure Syringe Market

Major companies operating in the medical high pressure syringe market are Cardinal Health Inc., Bayer AG, Medline Industries Inc., Becton Dickinson and Company, GE Healthcare Technologies Inc., Terumo Corporation, Gerresheimer AG, Merit Medical Systems Inc., MedNet GmbH, B. Braun Melsungen AG, Ulrich GmbH & Co. KG, Hawkmed (Shenzhen Hawk Medical Instrument Co. Ltd.), Kemper Medical Inc., Smiths Medical (ICU Medical Inc.), APOLLO RT Co. Ltd., Hindustan Syringes & Medical Devices Limited, Guerbet Group, Bracco Imaging S.p.A., Nemoto Kyorindo Co. Ltd., Medrad (Bayer Radiology), AngioDynamics Inc., Shenzhen Antmed Co. Ltd.

Global Medical High Pressure Syringe Market Trends and Insights

Major companies operating in the medical high pressure syringe market are focusing on developing innovative technologies, such as needle-free technology to improve patient safety and enhance injection efficiency. Needle-free technology refers to a method of delivering medications or fluids without using traditional needles, aiming to reduce pain, minimize infection risk, and enhance patient compliance. For instance, in November 2024, Sol-Millennium Medical Group a US-based Medical Group launched Revolutionary Needle-Free Injection Device for Insulin Administration in Canada designed specifically for insulin delivery. This innovative technology aims to enhance patient comfort and compliance by eliminating the pain and fear associated with traditional needles. The device leverages high-pressure technology to deliver insulin through the skin without puncturing it. Its launch represents a significant advancement in diabetes care, offering a more user-friendly alternative for insulin-dependent individuals. This move also marks Sol-Millennium's strategic expansion into the Canadian medical device market.

What Are Latest Mergers And Acquisitions In The Medical High Pressure Syringe Market?

In May 2024, Nordson Corporation, a US-based precision technology company that provides dispensing, fluid solutions, and medical device systems, acquired Atrion Corporation, a US-based provider of medical infusion fluid delivery and cardiovascular inflation solutions, for roughly US$ 800 million. With this acquisition, Nordson expanded its medical and fluid solutions portfolio into infusion and high-precision fluid delivery systems. Atrion is a US-based medical company specializing in medical high-pressure syringes.

Regional Outlook

North America was the largest region in the medical high pressure Syringe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Medical High Pressure Syringe Market?

The medical high pressure syringe market consists of sales of CT high-pressure syringes, angiographic syringes, and automated injector-compatible syringes. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.